This session provides a pharmacotherapy update for 2010-2011. New medications, new dosage forms, and new guidelines and clinical trials that have implications for the geriatric nurse practitioner are highlighted. Comparative trials of these new medications to existing therapies within a therapeutic class are discussed for relevance in geriatrics.
Discuss the new molecular entities from 2011-2012 and their application to geriatrics medicine and practice.
Identify the new dosage forms (2011-2012) of existing medications and their utility in geriatrics.
Enumerate some published clinical trials for these newly approved medications and how they might compare to existing therapies within a therapeutic class.